# ZARS

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zars

- Industry: Pharmaceuticals
- Headquarters: Salt Lake City, US
- Total disclosed funding: $30M
- Latest round: Series C (Sep 1, 2004)
- Investors on record: 7

## About

Founded in 1996, based in US, ZARS, Inc. is a specialty pharmaceutical company. IT develops topically administered drugs primarily in the area of pain management.

## Funding rounds

- Series C, Sep 1, 2004, $19M — Draper Fisher Jurvetson, EPIC Ventures, ePlanet Capital, CDIB BioScience Venture Management, Tenex Capital Fund
- Series B, Nov 12, 2003, $5M — EPIC Ventures, Cephalon, Zions SBIC, Tenex Capital Fund
- Series A, May 1, 2002, $6.3M — EPIC Ventures

## Investors

- EPIC Ventures (https://capitalatlas.ai/funds/epic-ventures) — Series A, Series B, Series C
- Cephalon — Series B
- Zions SBIC — Series B
- Tenex Capital Fund — Series B, Series C
- Draper Fisher Jurvetson (https://capitalatlas.ai/funds/draper-fisher-jurvetson) — Series C
- ePlanet Capital (https://capitalatlas.ai/funds/eplanet-capital) — Series C
- CDIB BioScience Venture Management (https://capitalatlas.ai/funds/cdib-bioscience-venture-management) — Series C